| | | | | |
ANIK Anika Therapeutics Inc | $21,1600 | -0,47% | $294,82M | $21,47K | |
BACC Blue Acquisition Corp. Class A Ordinary Shares | $10,4890 | +0,09% | $294,73M | $140,00 | |
GPAC General Purpose Acquisition Corp. Class A Ordinary Shares | $10,0400 | +0,00% | $294,68M | $12,00 | |
BPRN Princeton Bancorp, Inc. Common Stock (PA) | $42,0550 | -0,06% | $294,53M | $5,70K | |
| $42,9760 | -1,41% | $294,35M | $1,46K | |
ACGC ACP Holdings Acquisition Corp. Class A Ordinary Shares | $10,0240 | +0,24% | $294,35M | $178,00 | |
HCAC Hall Chadwick Acquisition Corp Class A Ordinary Shares | $10,0800 | +0,00% | $294,33M | $168,00 | |
SLN Silence Therapeutics Plc American Depository Share | $13,2820 | -2,41% | $294,27M | $130,83K | |
MTNE CH4 Natural Solutions Corporation | $9,8940 | +0,04% | $293,88M | $6,000 | |
RXST RxSight, Inc. Common Stock | $6,1150 | -0,73% | $293,64M | $169,65K | |
NHIC NewHold Investment Corp III Class A Ordinary shares | $10,6300 | -0,05% | $293,52M | $402,67K | |
IRHO Iron Horse Acquisitions II Corp. Common Stock | $10,0250 | +0,00% | $293,49M | $554,00 | |
CNXU Conexeu Sciences Inc. Common Stock | $9,4150 | +5,08% | $293,27M | $85,58K | |
| $10,1790 | -1,46% | $292,98M | $239,20K | |
JCE Nuveen Core Equity Alpha Fund | $16,9750 | +0,06% | $292,78M | $5,95K | |
